Cancer/Tumor Profiling Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Cancer/Tumor Profiling Market to 2027 - Global Analysis and Forecasts by Technology (Immunoassays, Hybridization, Sequencing Techniques, Mass Spectrometry, and Others), Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Application (Clinical Application and Research Application) and Geography

Report Code: TIPRE00003122 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Tumor profiling services use a variety of methods for the examination of patient's tumor. Some utilize next generation DNA sequencing or RNA sequencing, while others analyze protein expression. Multiple technologies are used to provide very specific information about the molecular and genetic makeup of the tumor. Tumor profiling companies utilize various methods to examine the biopsy sample, and return information about the genes altered in the cancer cells.

The cancer/tumor profiling market is expected to grow in the forecast period owing to key factors such as growing number of new cancer cases, rising utility of biomarkers in tumor profiling, and availability of funding for cancer research. The market is likely to experience the growth opportunities in the emerging nations and the technological advancements, increasing demand for point-of-care diagnostic tests are likely to develop innovative products.

The "Global Cancer/Tumor Profiling Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global cancer/tumor profiling market with detailed market segmentation by technology, cancer type, application, and geography. The global Cancer/Tumor Profiling market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cancer/Tumor Profiling market players and offers key trends and opportunities in the market.

The global cancer/tumor profiling market is segmented on the basis of technology, cancer type and application. Based on technology, the market is segmented as immunoassays, hybridization, sequencing techniques, mass spectrometry, and others. On the basis of cancer type, the cancer/tumor profiling market segmentation is classified as lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma cancer, and others. Based on the application the market is segmented as clinical application and research application.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer/tumor profiling market based on technology, cancer type and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer/tumor profiling market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the cancer/tumor profiling market in the forecast period due to presence of major players and rapid advances in technology, high prevalence of cancer and increased research in oncology to identify and discover innovative therapy for cancer treatment. Asia Pacific is anticipated to be the fastest growing region due to the increasing incidence of cancer, rising demand for better healthcare services in developing economies such as India and China, growing number of contract research organizations (CROs), and increasing focus of international players on emerging markets.

The report analyzes factors affecting cancer/tumor profiling market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cancer/tumor profiling market in these regions.

The report also includes the profiles of key cancer/tumor profiling market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the cancer/tumor profiling market include, Illumina, Inc., Qiagen N.V., NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health, Caris Life Sciences, Helomics Corp., NanoString Technologies, Inc., Oxford Gene Technology, and Ribomed Biotechnologies, Inc. among others.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Cancer/Tumor Profiling Market- By Technology
1.3.2. Cancer/Tumor Profiling Market- By Cancer Type
1.3.3. Cancer/Tumor Profiling Market- By Application
1.3.4. Cancer/Tumor Profiling Market- By Region
1.3.4.1. By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NONINVASIVE PRENATAL DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. CANCER/TUMOR PROFILING MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CANCER/TUMOR PROFILING MARKET- GLOBAL ANALYSIS
6.1. CANCER/TUMOR PROFILING MARKET - GLOBAL MARKET OVERVIEW
6.2. CANCER/TUMOR PROFILING MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. CANCER/TUMOR PROFILING MARKET REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOASSAYS MARKET
7.3.1. Overview
7.3.2. Immunoassays Market Forecast and Analysis (US$ Mn)
7.4. HYBRIDIZATION MARKET
7.4.1. Overview
7.4.2. Hybridization Market Forecast and Analysis (US$ Mn)
7.5. SEQUENCING TECHNIQUES MARKET
7.5.1. Overview
7.5.2. Sequencing Techniques Market Forecast and Analysis (US$ Mn)
7.6. MASS SPECTROMETRY MARKET
7.6.1. Overview
7.6.2. Mass Spectrometry Market Forecast and Analysis (US$ Mn)
7.7. OTHERS MARKET
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis (US$ Mn)

?
8. CANCER/TUMOR PROFILING MARKET REVENUE AND FORECASTS TO 2027 - CANCER TYPE
8.1. OVERVIEW
8.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
8.3. LUNG CANCER MARKET
8.3.1. Overview
8.3.2. Lung Cancer Market Forecast and Analysis (US$ Mn)
8.4. BREAST CANCER MARKET
8.4.1. Overview
8.4.2. Breast Cancer Market Forecast and Analysis (US$ Mn)
8.5. COLORECTAL CANCER MARKET
8.5.1. Overview
8.5.2. Colorectal Cancer Market Forecast and Analysis (US$ Mn)
8.6. PROSTATE CANCER MARKET
8.6.1. Overview
8.6.2. Prostate Cancer Market Forecast and Analysis (US$ Mn)
8.7. MELANOMA CANCER MARKET
8.7.1. Overview
8.7.2. Melanoma Cancer Market Forecast and Analysis (US$ Mn)
8.8. OTHERS MARKET
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis (US$ Mn)

9. CANCER/TUMOR PROFILING MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CLINICAL APPLICATION MARKET
9.3.1. Overview
9.3.2. Clinical Application Market Forecast and Analysis (US$ Mn)
?
9.4. RESEARCH APPLICATION MARKET
9.4.1. Overview
9.4.2. Research Application Market Forecast and Analysis (US$ Mn)

10. CANCER/TUMOR PROFILING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA CANCER/TUMOR PROFILING MARKET
10.1.1. North America Cancer/Tumor Profiling Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.3. North America Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.1.4. North America Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.1.5. North America Cancer/Tumor Profiling Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.6.2. US Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.1.6.3. US Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.7.2. Canada Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.1.7.3. Canada Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.1.8.2. Mexico Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.1.8.3. Mexico Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.2. EUROPE CANCER/TUMOR PROFILING MARKET
10.2.1. Europe Cancer/Tumor Profiling Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.3. Europe Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.2.4. Europe Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.2.5. Europe Cancer/Tumor Profiling Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.6.2. UK Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.2.6.3. UK Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.7.2. Germany Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.2.7.3. Germany Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.8.2. France Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.2.8.3. France Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.9.2. Italy Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.2.9.3. Italy Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.2.10.2. Spain Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.2.10.3. Spain Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.3. ASIA PACIFIC CANCER/TUMOR PROFILING MARKET
10.3.1. Asia Pacific Cancer/Tumor Profiling Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.3. Asia Pacific Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.3.4. Asia Pacific Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.3.5. Asia Pacific Cancer/Tumor Profiling Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.6.2. Japan Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.3.6.3. Japan Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7. India Market Overview
10.3.7.1. India Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.7.2. India Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.3.7.3. India Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8. China Market Overview
10.3.8.1. China Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.8.2. China Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.3.8.3. China Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.9.2. South Korea Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.3.9.3. South Korea Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.3.10.2. Australia Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.3.10.3. Australia Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) CANCER/TUMOR PROFILING MARKET
10.4.1. Middle East & Africa (MEA) Cancer/Tumor Profiling Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.3. Middle East & Africa (MEA) Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.4.4. Middle East & Africa (MEA) Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.4.5. Middle East & Africa (MEA) Cancer/Tumor Profiling Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.6.2. South Africa Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.4.6.3. South Africa Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.7.2. Saudi Arabia Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.4.7.3. Saudi Arabia Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.4.8.2. UAE Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.4.8.3. UAE Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA CANCER/TUMOR PROFILING MARKET
10.5.1. South and Central America Cancer/Tumor Profiling Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.3. South and Central America Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.5.4. South and Central America Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
10.5.5. South and Central America Cancer/Tumor Profiling Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.6.2. Brazil Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.5.6.3. Brazil Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)
?
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Cancer/Tumor Profiling Market Forecasts and Analysis - By Technology (US$ Mn)
10.5.7.2. Argentina Cancer/Tumor Profiling Market Forecasts and Analysis - By Cancer Type (US$ Mn)
10.5.7.3. Argentina Cancer/Tumor Profiling Market Forecasts and Analysis - By Application (US$ Mn)

11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions

12. CANCER/TUMOR PROFILING MARKET, KEY COMPANY PROFILES
12.1. ILLUMINA, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. QIAGEN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
?
12.3. NEOGENOMICS LABORATORIES, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HTG MOLECULAR DIAGNOSTICS, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GENOMIC HEALTH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CARIS LIFE SCIENCES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
?
12.7. HELOMICS CORP.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NANOSTRING TECHNOLOGIES, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. OXFORD GENE TECHNOLOGY
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. RIBOMED BIOTECHNOLOGIES, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments

?
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Illumina, Inc.
2. QIAGEN
3. NeoGenomics Laboratories, Inc.
4. HTG Molecular Diagnostics, Inc.
5. Genomic Health
6. Caris Life Sciences
7. Helomics Corp.
8. NanoString Technologies, Inc.
9. Oxford Gene Technology
10. Ribomed Biotechnologies, Inc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book